BioHarvest Sciences Inc. reiterated its sales orders guidance for 2022. The company reiterated its 2022 sales orders guidance of USD 5 million - USD 7 million representing a 2.5 times - 3.5 times growth over 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.255 CAD | -1.92% | -1.92% | +18.60% |
1st Jan change | Capi. | |
---|---|---|
+18.60% | 107M | |
+13.21% | 8.15B | |
+3.16% | 7.52B | |
+12.30% | 6.65B | |
-5.71% | 3.73B | |
-6.99% | 3.72B | |
-4.78% | 1.31B | |
+12.61% | 972M | |
-37.22% | 958M | |
-15.02% | 876M |
- Stock Market
- Equities
- BHSC Stock
- News BioHarvest Sciences Inc.
- BioHarvest Sciences Inc. Reiterates Sales Orders Guidance for 2022